News

90 seconds to learn more about YSOPIA Bioscience

Jun 1, 2021

In the same category

News

YSOPIA Bioscience Announces First Signs of Biological Activity from Phase I Analysis of Xla1, its...

Dec 2, 2021

more +
News

YSOPIA Bioscience Announces Leadership Team Reorganization and Appoints Co-Founder & CFO Fabrice...

Nov 1, 2021

more +
News

YSOPIA Successfully Completes Phase 1 Clinical Study of Xla1 Biotherapy for the Treatment of Obesity...

Jul 6, 2021

more +

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions